CALCA and metabolic dysfunction-associated steatotic liver disease: We conclude by discussing the epigenetic regulation of KC function in non-alcoholic fatty liver disease (NAFLD) and how knowledge of KC epigenetics could guide the development of future NAFLD therapies.